Orient Paper Narrows Q2 FY27 Loss 6% as Revenue Falls 8.3%
Key highlights
- Orient Paper reported a Q2 FY27 net loss of ₹28.75 crore, 6.0% lower year-on-year.
- Q2 FY27 revenue from operations declined 8.3% year-on-year to ₹183.14 crore.
- The Paper & Tissue segment posted a ₹29.49 crore loss, while Chemicals earned ₹0.38 crore.
- The Board appointed Ernst & Young LLP as internal auditor for Q3 and Q4 of FY27.
powered by IRIS

Orient Paper & Industries Limited narrowed its net loss by 6% year-on-year to ₹28.75 crore in the September 2026 quarter, while revenue from operations declined 8.3% to ₹183.14 crore. The Q2 FY27 result matters because the company reduced losses despite lower sales, although its core Paper & Tissue segment remained loss-making.
Know Orient Paper & Industries inside out
Results, valuation, peers and who's buying, in one view.
What did Orient Paper report for Q2 FY27?
Orient Paper reported a standalone net loss of ₹28.75 crore for the quarter ended September 30, 2026, compared with a loss of ₹30.60 crore in the corresponding quarter a year earlier. Revenue from operations fell to ₹183.14 crore from ₹199.75 crore in Q2 FY26.
The loss before tax narrowed 9.2% to ₹38.51 crore from ₹42.41 crore. The company reported a negative operating profit of ₹23.23 crore, compared with negative operating profit of ₹32.36 crore in the year-earlier period. This represents a 28.21% improvement in the operating loss, based on the reported figures.
Why did the quarterly loss narrow despite lower revenue?
Orient Paper's reported numbers show that the quarterly loss narrowed even as revenue decreased, because the operating loss and loss before tax were lower than in Q2 FY26. The company did not provide further details in the supplied information on the specific cost, pricing, volume, or other factors behind the change.
The Paper & Tissue segment continued to be the main loss-making business. Its segment result was a loss of ₹29.49 crore during Q2 FY27. By contrast, the Chemicals segment recorded a profit of ₹0.38 crore, making it the profitable segment in the reported quarter.
The segment figures show that the improvement in the overall loss did not amount to a return to profitability in the company’s principal paper business. Revenue contraction also remains significant, as sales were lower by ₹16.61 crore from the level reported in the September 2025 quarter.
When were the Q2 FY27 results approved and reviewed?
Orient Paper's Board of Directors approved the unaudited standalone results for the quarter and half year ended September 30, 2026, at its meeting on November 5, 2026. The meeting covered the July-to-September reporting period and was conducted under the applicable SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The financial statements were subject to a limited review by B S R & Co. LLP, the statutory auditors. A limited review is the review process used for quarterly unaudited financial results of listed companies, rather than a full-year audit.
The company had earlier notified the exchanges that its Board would meet on November 5 to consider the September-quarter and half-year results. Indian listed companies are required to publish quarterly results within 45 days of the quarter-end, placing the outer reporting deadline for the September 2026 quarter on November 14, 2026.
Got a follow-up? Ask IRIS
What other decision did the Board take?
Orient Paper's Board appointed Ernst & Young LLP as internal auditor for the second half of FY27, covering the third and fourth quarters. The appointment was approved alongside the September-quarter financial results on November 5.
Internal audit appointments relate to oversight of internal controls, processes and compliance. The supplied disclosure does not specify the scope of Ernst & Young LLP's engagement beyond its role as internal auditor for Q3 and Q4 of FY27.
This was a separate governance decision from the limited review of the Q2 results. B S R & Co. LLP remained the statutory auditor that conducted the limited review of the September-quarter financial statements.
How does the result compare with recent financial performance?
Orient Paper entered Q2 FY27 after reporting weaker year-on-year numbers in the June 2026 quarter. In Q1 FY27, revenue was ₹227.61 crore, down 4.5% from ₹238.34 crore in Q1 FY26, while the company recorded a net loss of ₹8.25 crore against a profit of ₹33.99 crore a year earlier.
The September-quarter result therefore extends a period in which reported revenue has been below the prior-year level. However, the Q2 net loss of ₹28.75 crore was lower than the ₹30.60 crore loss posted in Q2 FY26, indicating a year-on-year reduction in losses for that quarter.
For investors, the key reported indicators are the decline in revenue, the lower operating loss, and the continuing loss in the Paper & Tissue segment. The Chemicals segment was profitable in Q2 FY27, but its ₹0.38 crore segment result was small relative to the Paper & Tissue loss.
Conclusion
Orient Paper's Q2 FY27 results showed a narrower net loss and lower operating loss than a year earlier, but also an 8.3% decline in revenue. The reported improvement was supported by lower losses at the overall level, while the Paper & Tissue business continued to record a substantial segment loss.
The next disclosed operational marker is the second half of FY27, when Ernst & Young LLP will serve as internal auditor for Q3 and Q4. Investors will also monitor subsequent quarterly disclosures for changes in revenue, operating profitability and the segment performance of Paper & Tissue and Chemicals.


